Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;72(3):342-365.
doi: 10.1111/all.13077. Epub 2017 Jan 25.

Allergen Immunotherapy for Insect Venom Allergy: A Systematic Review and Meta-Analysis

Free article

Allergen Immunotherapy for Insect Venom Allergy: A Systematic Review and Meta-Analysis

S Dhami et al. Allergy. .
Free article

Erratum in

  • Corrigendum.
    Allergy. 2017 Oct;72(10):1590. doi: 10.1111/all.13229. Allergy. 2017. PMID: 28905456 No abstract available.


Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines on Allergen Immunotherapy (AIT) for the management of insect venom allergy. To inform this process, we sought to assess the effectiveness, cost-effectiveness and safety of AIT in the management of insect venom allergy.

Methods: We undertook a systematic review, which involved searching 15 international biomedical databases for published and unpublished evidence. Studies were independently screened and critically appraised using established instruments. Data were descriptively summarized and, where possible, meta-analysed.

Results: Our searches identified a total of 16 950 potentially eligible studies; of which, 17 satisfied our inclusion criteria. The available evidence was limited both in volume and in quality, but suggested that venom immunotherapy (VIT) could substantially reduce the risk of subsequent severe systemic sting reactions (OR = 0.08, 95% CI 0.03-0.26); meta-analysis showed that it also improved disease-specific quality of life (risk difference = 1.41, 95% CI 1.04-1.79). Adverse effects were experienced in both the build-up and maintenance phases, but most were mild with no fatalities being reported. The very limited evidence found on modelling cost-effectiveness suggested that VIT was likely to be cost-effective in those at high risk of repeated systemic sting reactions and/or impaired quality of life.

Conclusions: The limited available evidence suggested that VIT is effective in reducing severe subsequent systemic sting reactions and in improving disease-specific quality of life. VIT proved to be safe and no fatalities were recorded in the studies included in this review. The cost-effectiveness of VIT needs to be established.

Keywords: Allergy; anaphylaxis; hymenoptera venom allergy; insect venom allergy; systemic sting reaction.

Similar articles

See all similar articles

Cited by 9 articles

  • Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c.
    Klimek L, Pfaar O, Worm M, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Poethig D, Rabe K, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic PV, Aberer W, Fink-Wagner A, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Pohl W, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Akdis C, Hoffmann-Sommergruber K, Jutel M, Matricardi P, Spertini F, Khaltaev N, Michel JP, Nicod L, Schmid-Grendelmeier P, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Bousquet J, Zuberbier T, Vogelberg C, Gerstlauer M. Klimek L, et al. Allergo J. 2020;29(3):17-25. doi: 10.1007/s15007-020-2539-9. Epub 2020 May 8. Allergo J. 2020. PMID: 32362727 Free PMC article. Review. German. No abstract available.
  • Clinical Utility of Rush Venom Immunotherapy: Current Status.
    Gruzelle V, Mailhol C, Waters DW, Guilleminault L. Gruzelle V, et al. J Asthma Allergy. 2020 Jan 7;13:1-10. doi: 10.2147/JAA.S200917. eCollection 2020. J Asthma Allergy. 2020. PMID: 32021308 Free PMC article. Review.
  • Modulating local airway immune responses to treat allergic asthma: lessons from experimental models and human studies.
    Voskamp AL, Kormelink TG, van Wijk RG, Hiemstra PS, Taube C, de Jong EC, Smits HH. Voskamp AL, et al. Semin Immunopathol. 2020 Feb;42(1):95-110. doi: 10.1007/s00281-020-00782-4. Epub 2020 Feb 4. Semin Immunopathol. 2020. PMID: 32020335 Free PMC article. Review.
  • Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
    Sahiner UM, Durham SR. Sahiner UM, et al. Front Immunol. 2019 Aug 21;10:1959. doi: 10.3389/fimmu.2019.01959. eCollection 2019. Front Immunol. 2019. PMID: 31497015 Free PMC article. Review.
  • Venom allergy treatment practices in Poland in comparison to guidelines: next edition of the national audit.
    Cichocka-Jarosz E, Stobiecki M, Nittner-Marszalska M, Jedynak-Wąsowicz U, Brzyski P; Immunotherapy Section of the Polish Society of Allergology Working Group (PTA). Cichocka-Jarosz E, et al. Postepy Dermatol Alergol. 2019 Jun;36(3):346-353. doi: 10.5114/ada.2019.85642. Epub 2019 Jun 19. Postepy Dermatol Alergol. 2019. PMID: 31333352 Free PMC article.
See all "Cited by" articles

LinkOut - more resources